1. Home
  2. LUNG vs CPSH Comparison

LUNG vs CPSH Comparison

Compare LUNG & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • CPSH
  • Stock Information
  • Founded
  • LUNG 1995
  • CPSH 1984
  • Country
  • LUNG United States
  • CPSH United States
  • Employees
  • LUNG 291
  • CPSH N/A
  • Industry
  • LUNG Industrial Specialties
  • CPSH Building Materials
  • Sector
  • LUNG Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • LUNG Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • LUNG 63.6M
  • CPSH 51.9M
  • IPO Year
  • LUNG 2020
  • CPSH 1987
  • Fundamental
  • Price
  • LUNG $1.98
  • CPSH $4.02
  • Analyst Decision
  • LUNG Buy
  • CPSH
  • Analyst Count
  • LUNG 7
  • CPSH 0
  • Target Price
  • LUNG $7.66
  • CPSH N/A
  • AVG Volume (30 Days)
  • LUNG 827.7K
  • CPSH 338.3K
  • Earning Date
  • LUNG 10-29-2025
  • CPSH 10-30-2025
  • Dividend Yield
  • LUNG N/A
  • CPSH N/A
  • EPS Growth
  • LUNG N/A
  • CPSH N/A
  • EPS
  • LUNG N/A
  • CPSH N/A
  • Revenue
  • LUNG $90,549,000.00
  • CPSH $25,764,977.00
  • Revenue This Year
  • LUNG $10.30
  • CPSH N/A
  • Revenue Next Year
  • LUNG $14.72
  • CPSH N/A
  • P/E Ratio
  • LUNG N/A
  • CPSH N/A
  • Revenue Growth
  • LUNG 18.24
  • CPSH 7.46
  • 52 Week Low
  • LUNG $1.47
  • CPSH $1.39
  • 52 Week High
  • LUNG $9.37
  • CPSH $4.89
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 62.99
  • CPSH 53.51
  • Support Level
  • LUNG $1.56
  • CPSH $3.73
  • Resistance Level
  • LUNG $1.67
  • CPSH $4.07
  • Average True Range (ATR)
  • LUNG 0.15
  • CPSH 0.37
  • MACD
  • LUNG 0.03
  • CPSH -0.04
  • Stochastic Oscillator
  • LUNG 33.58
  • CPSH 34.61

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: